Nrx Pharmaceuticals Inc (NRXP)

$2.33

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $2.33
    $2.40
    $2.33
    downward going graph

    0.0%

    Downside

    Day's Volatility :2.92%

    Upside

    2.92%

    downward going graph
  • $1.90
    $7.33
    $2.33
    downward going graph

    18.45%

    Downside

    52 Weeks Volatility :74.08%

    Upside

    68.21%

    downward going graph

Returns

PeriodNrx Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-22.33%
6.4%
0.0%
6 Months
-46.76%
6.0%
0.0%
1 Year
-43.39%
8.5%
0.0%
3 Years
-97.7%
14.6%
-20.8%

Highlights

Market Capitalization
24.9M
Book Value
- $1.55
Earnings Per Share (EPS)
5.2
PE Ratio
0.45
Wall Street Target Price
31.5
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-118.07%
Return On Equity TTM
-682.61%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-24.1M
Diluted Eps TTM
5.2
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-3.21
EPS Estimate Next Year
-1.85
EPS Estimate Current Quarter
-0.55
EPS Estimate Next Quarter
-0.55

Analyst Recommendation

Buy
    88%Buy
    11%Hold
    0
    0%Sell
Based on 9 Wall street analysts offering stock ratings for Nrx Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 1251.93%

Current $2.33
Target $31.50

Technicals Summary

Sell

Neutral

Buy

Nrx Pharmaceuticals Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Nrx Pharmaceuticals Inc
Nrx Pharmaceuticals Inc
-12.08%
-46.76%
-43.39%
-97.7%
-90.39%
Moderna, Inc.
Moderna, Inc.
-9.19%
21.5%
-4.18%
-62.27%
762.21%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
0.99%
12.81%
44.78%
82.21%
258.69%
Novo Nordisk A/s
Novo Nordisk A/s
-7.34%
24.69%
58.81%
196.23%
443.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.88%
11.69%
35.62%
150.46%
182.38%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Nrx Pharmaceuticals Inc
Nrx Pharmaceuticals Inc
0.45
0.45
NA
-3.21
-6.83
-1.18
NA
-1.55
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.53
31.53
1.46
44.41
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.49
45.49
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.66
31.66
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Nrx Pharmaceuticals Inc
Nrx Pharmaceuticals Inc
Buy
$24.9M
-90.39%
0.45
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.5B
762.21%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.5B
258.69%
31.53
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$589.9B
443.55%
45.49
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.0B
182.38%
31.66
39.46%

Insights on Nrx Pharmaceuticals Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 58.8% return, outperforming this stock by 102.2%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 196.2% return, outperforming this stock by 293.9%

Institutional Holdings

  • Vanguard Group Inc

    1.35%
  • Geode Capital Management, LLC

    0.39%
  • BlackRock Inc

    0.27%
  • Renaissance Technologies Corp

    0.19%
  • One Wealth Management Investment & Advisory Services LLC

    0.13%
  • Bridgeway Capital Management, LLC

    0.11%

Company Information

Organization
Nrx Pharmaceuticals Inc
Employees
0
CEO
Dr. Jonathan C. Javitt M.D., M.P.H.
Industry
Services

FAQs